Recruiting NA Pediatric Asthma

New treatment option for Pediatric Asthma

Official title The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

ClinicalTrials.gov ID: NCT05999032

What this study is testing

What it's testing
The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden.
  • Time commitment: about 5 months

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 2 to 12

You may be able to join if

  • Children between the ages of 2 and 12 years old
  • Children must reside in one of the identified catchment areas
  • Children must meet the screening criteria as having not well controlled or poorly controlled asthma

You likely can't join if

  • 1\. Children with complex medical conditions

The study team makes the final eligibility decision.

Where it's taking place

  • Providence, Rhode Island, United States
  • San Juan, Puerto Rico, Puerto Rico

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 5 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 2 years to 12 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Providence, Rhode Island, United States; San Juan, Puerto Rico, Puerto Rico. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.